Foresite Capital Management V 13F annual report

Foresite Capital Management V is an investment fund managing more than $157 billion ran by James Tananbaum. There are currently 5 companies in Mr. Tananbaum’s portfolio. The largest investments include Alumis Inc and Hims & Hers Health, together worth $110 billion.

$157 billion Assets Under Management (AUM)

As of 6th August 2024, Foresite Capital Management V’s top holding is 5,584,887 shares of Alumis Inc currently worth over $74.3 billion and making up 47.4% of the portfolio value. In addition, the fund holds 1,759,314 shares of Hims & Hers Health worth $35.5 billion, whose value grew 88.2% in the past six months. The third-largest holding is Cg Oncology, Inc. worth $21.9 billion and the next is Disc Medicine, Inc. worth $13.5 billion, with 299,069 shares owned.

Currently, Foresite Capital Management V's portfolio is worth at least $157 billion. The total portfolio value may be much higher due to cash assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.

Careers at Foresite Capital Management V

The Foresite Capital Management V office and employees reside in Larkspur, California. According to the last 13-F report filed with the SEC, James Tananbaum serves as the Managing Member at Foresite Capital Management V.

Recent trades

In the most recent 13F filing, Foresite Capital Management V revealed that it had opened a new position in Alumis Inc and bought 5,584,887 shares worth $74.3 billion.

The investment fund also strengthened its position in Disc Medicine, Inc. by buying 55,556 additional shares. This makes their stake in Disc Medicine, Inc. total 299,069 shares worth $13.5 billion.

On the other hand, there are companies that Foresite Capital Management V is getting rid of from its portfolio. Foresite Capital Management V closed its position in Kinnate Biopharma on 13th August 2024. It sold the previously owned 3,525,957 shares for $9.38 billion. James Tananbaum also disclosed a decreased stake in Hims & Hers Health by 0.5%. This leaves the value of the investment at $35.5 billion and 1,759,314 shares.

One of the smallest hedge funds

The two most similar investment funds to Foresite Capital Management V are Gridiron Partners and Kanen Wealth Management. They manage $157 billion and $157 billion respectively.

James Tananbaum investment strategy

Foresite Capital Management V’s portfolio is diversified across 2 sectors. Currently, their heaviest sector is Consumer Staples — making up 22.7% of the total portfolio value. The fund focuses on investments in the United States as 20.0% of the portfolio companies are based in the United States.

The majority of the companies in the fund’s portfolio are large-cap stocks. Stocks with a size of more than $10 billion in market cap make up approximately 0.1% of the total holdings value. On the other hand, small-cap stocks make up only approximately 0.1% of the portfolio. The average market cap of the portfolio companies is close to $1.41 billion.

The complete list of Foresite Capital Management V trades based on 13F SEC filings

These positions were updated on August 13th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.

Security	Shares Owned	Value	Allocation
Alumis Inc	Opened 5,584,887	$74,278,997,000	47.43%
Hims & Hers Health, Inc.	47.12% 1,759,314	$35,520,550,000	22.68%
Cg Oncology, Inc.	No change 692,550	$21,863,804,000	13.96%
Disc Medicine, Inc.	22.81% 299,069	$13,479,040,000	8.61%
Cullinan Therapeutics Inc	Opened 657,905	$11,473,863,000	7.33%
Kinnate Biopharma Inc.	Closed 3,525,957	$9,379,046,000
23andme Holding Co.	Closed 232,200	$123,530,000
No transactions found
Showing first 500 out of 7 holdings